(Q34196883)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420578%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

meta-analysis

0 references

title

Effect of molecular weight and substitution on tissue uptake of hydroxyethyl starch: a meta-analysis of clinical studies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420578%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420578%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Clemens Feistritzer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420578%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Christian J Wiedermann

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420578%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

1 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420578%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacokinetics

26 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420578%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420578%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420578%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

225-236

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420578%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/11594700-000000000-00000

26 January 2020

exact match

0 references

cites work

Preferred plasma volume expanders for critically ill patients: results of an international survey.

1 reference

https://api.crossref.org/works/10.2165%2F11594700-000000000-00000

A systematic review of the comparative safety of colloids

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594700-000000000-00000

Pruritus precipitated by hydroxyethyl starch: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594700-000000000-00000

Hydrops lysosomalis generalisatus--an underestimated side effect of hydroxyethyl starch therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594700-000000000-00000

21 January 2018

Hydroxyethyl Starches

1 reference

https://api.crossref.org/works/10.2165%2F11594700-000000000-00000

Hydroxyethyl starch (HES) [130/0.4], a new HES specification: pharmacokinetics and safety after multiple infusions of 10% solution in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594700-000000000-00000

Differential storage of hydroxyethyl starch (HES) in the skin: an immunoelectron-microscopical long-term study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594700-000000000-00000

Endothelial accumulation of hydroxyethyl starch and functional consequences on leukocyte-endothelial interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594700-000000000-00000

Clinical Trial of 6% Hydroxyethyl Starch (a New Plasma Expander)

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594700-000000000-00000

Hydroxyethyl starch: an agent for hypovolemic shock treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594700-000000000-00000

Hydroxyethyl starch. An agent for hypovolaemic schock treatment II. Urinary excretion in normal volunteers following three consecutive daily infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594700-000000000-00000

Plasma clearance and renal excretion of erythrocyte cryoprotectant hydroxyethylated amylopectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594700-000000000-00000

A clinical study of low molecular weight-hydroxyethyl starch, a new plasma expander

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594700-000000000-00000

Urinary excretion kinetics of hydroxyethyl starch 350/0.60 in normovolaemic man.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594700-000000000-00000

Acetyl starch as volume substitute, a possible alternative to HES

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594700-000000000-00000

The in vivo molecular weight and renal threshold of hydroxyethyl starch in the example of molar substituted HES70/0/5

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594700-000000000-00000

Hydroxyethyl starch in balanced electrolyte solution (Hextend)--pharmacokinetic and pharmacodynamic profiles in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594700-000000000-00000

HES 130/0.42 shows less alteration of pharmacokinetics than HES 200/0.5 when dosed repeatedly

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594700-000000000-00000

Bioequivalence comparison between hydroxyethyl starch 130/0.42/6 : 1 and hydroxyethyl starch 130/0.4/9 : 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594700-000000000-00000

Pharmacodynamics and organ storage of hydroxyethyl starch in acute hemodilution in pigs: influence of molecular weight and degree of substitution

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594700-000000000-00000

Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594700-000000000-00000

Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594700-000000000-00000

Decreased activity of acid alpha-glucosidase in a patient with persistent periocular swelling after infusions of hydroxyethyl starch

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594700-000000000-00000

Worsening of hepatic dysfunction as a consequence of repeated hydroxyethylstarch infusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594700-000000000-00000

Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594700-000000000-00000

Hydroxyethyl starch--can the safety problems be ignored?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594700-000000000-00000

Renal impact of fluid management with colloids: a comparative review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594700-000000000-00000

Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594700-000000000-00000

Biliary excretion of hydroxyethyl starch in man

21 January 2018

1 reference

12 December 2020

Clinical evaluation of a new plasma expander hydroxyethyl starch

1 reference

12 December 2020

[The accumulation of different substituted hydroxyethyl starches (HES) following repeated infusions in healthy volunteers]

1 reference

12 December 2020

Acute renal failure secondary to hydroxyethylstarch administration in a surgical patient

1 reference

12 December 2020

Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function

1 reference

12 December 2020

[The elimination of hydroxyethyl starch 200/0.5, dextran 40 and oxypolygelatine (author's transl)]

1 reference

12 December 2020

Studies on hydroxyethyl starch. Part II: Changes of the molecular weight distribution for hydroxyethyl starch types 450/0.7, 450/0.5, 450/0.3, 300/0.4, 200/0.7, 200/0.5, 200/0.3 and 200/0.1 after infusion in serum and urine of volunteers.

1 reference

12 December 2020

Renal outcomes and mortality following hydroxyethyl starch resuscitation of critically ill patients: systematic review and meta-analysis of randomized trials: ATTENTION: The analysis and conclusions of this article are being revised by the authors.

1 reference

12 December 2020

Pharmacokinetics of middle-molecular hydroxyethyl starch (HAS 200/0,5

1 reference

12 December 2020

Intravascular persistence, tissue storage, and excretion of hydroxyethyl starch

1 reference

12 December 2020

Determination of the plasma elimination of hydroxyethyl starch and dextran using improved analytical methods

1 reference

12 December 2020

Hydroxyethyl starch (HAS 450/0.7) in human plasma and liver. Course of concentration and histological changes

1 reference

12 December 2020

The catabolism of low molecular weight-hydroxyethylated amylopectin in man. II. Changes in the urinary molecular profiles.

1 reference

12 December 2020

The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild-to-severe renal impairment

1 reference

12 December 2020

The effects of 500 ml 10% hydroxyethyl starch 200/0.5 and 10% dextran 40 on blood volume, colloid osmotic pressure and renal function in human volunteers (author's transl)

1 reference

12 December 2020

Pharmacokinetics and Tolerability of a New Hydroxyethyl Starch (HES) Specification [HES (130/0.4)] after Single-Dose Infusion of 6% or 10% Solutions in Healthy Volunteers

1 reference

12 December 2020

Catabolism of low-molecular-weight hydroxyethylated amylopectin in man. I. Changes in the circulating molecular composition

1 reference

12 December 2020

[Reply to W. L. Thompson's commentary (Infusionstherapie 4:56-62 1977) on G. Lindblad's and J. Falk's study on "Course of hydroxyethyl starch and dextran concentration in blood and liver of rabbits and the histopathological consequences of hydroxyet

1 reference

12 December 2020

Tissue deposits of hydroxyethyl starch (HES): dose-dependent and time-related

1 reference

12 December 2020

Preliminary report on the use of hydroxyethyl starch solution in man

1 reference

12 December 2020

Intestinal elimination of hydroxyethyl starch?

1 reference

12 December 2020

HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics.

1 reference

12 December 2020

A clinical physiologic study of hydroxyethyl starch

1 reference

12 December 2020

Pharmacokinetics of Hydroxyethyl Starch in Normal Subjects

1 reference

12 December 2020

Persistent pruritus after hydroxyethyl starch infusion therapy: a result of long-term storage in cutaneous nerves

1 reference

12 December 2020

Ascites as a complication of hepatic storage of hydroxyethyl starch in long-term dialysis

1 reference

12 December 2020

Effect of Hydroxyethyl Starch and Dextran on Plasma Volume and Blood Hemostasis and Coagulation

1 reference

12 December 2020

10.2165/11594700-000000000-00000

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420578%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

26 January 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420578%20AND%20SRC:MED&resulttype=core&format=json